Skip to main content
Journal of Research in Health Sciences logoLink to Journal of Research in Health Sciences
. 2016 Aug 29;16(3):116–121.

Impact of HIV Status Notification on Risk Behaviors among Men Who Inject Drugs in Kermanshah, West of Iran

Alireza Noroozi a, Ali Mirzazadeh b,c, Ali Farhoudian d, Ahmad Hajebi e, Hamid Reza Khankeh f,g, Peter Higgs h, Hamid Sharifi c, Bahram Armoon i, Mehdi Noroozi d,*
PMCID: PMC7191024  PMID: 27840338

Abstract

Background: It is unclear whether knowing of current HIV status is associated with change in injecting behaviors among people who inject drugs (PWID) in Iran. The objective of the present study was to determine whether awareness of HIV positive status is associated with a reduction in injecting risk behaviors, after matching for socio-demographic characteristics.

Methods: Five hundred male PWID were recruited in 2014 from two drop-in centers (DICs) in Kermanshah west of Iran. Trained interviewers collected data on socio-demographic characteristics, HIV testing and drug-related risk behaviors over the last month prior to interview using a structured questionnaire. Our primary exposure of interest was awareness of HIV status used to group participants into three categories: positive, negative, unaware. We used coarsened exact matching to make the three groups statistically equivalent based on age, place of residence, education and income, and then compared them regarding the proportion of borrowing, lending and reuse of syringes.

Results: Matched sample (n=320) had a mean age ± standard deviation (SD) of 33.5 ±7.6 yr. Overall, 25% (95% CI: 14%, 32%) of participants reported "borrowing a syringe" in the past month and 15% (95% CI: 7%, 22%) of them reported "lending a used syringe" to others in the past month. In comparison to PWID who were unaware of their HIV status, those knew they were HIV positive (OR 1.68, CI95%1.32–2.81) or negative (OR 1.54; 95% CI: 1.28, 2.71) were both more likely to report borrowing syringes in past month.

Conclusions: PWID WHO know they are positive for HIV are more likely to borrow another person’s syringe, to report reuse of their own used syringes and less likely to report lending their syringes to others. Strategies to scale up HIV testing and counseling for PWID, which also increase awareness of HIV status, may decrease injecting related the risk behaviors.

Keywords: Coarsened exact matching, People who inject drugs, Risk behaviors

Introduction

Drug injection is responsible for a large proportion of the blood-borne transmitted disease burden in both developed and developing countries1. Behaviors associated with injection drug use that are responsible for HIV transmission, such as sharing of injection equipment (especially needles and syringes), and unprotected vaginal and anal intercourse with an injecting drug user are considered as main routes of HIV and other blood-borne viruses (NNV) transmission2-4. It is estimated that between 170,000 and 230,000 people use drugs through injection5,6 and about two-thirds of new HIV infections are attributed to unsafe drug injection in Iran5-8. The prevalence of hepatitis C virus (HCV) infection is also very high amongst people who inject drugs (PWID) in the country, with studies reporting 50% to 75% of them are HCV positive depending on the setting of the study9.

Approaches to HIV and HCV risk reduction among PWID include drug treatment, HIV testing and counseling programs, street-based outreach conducted by peer educators, individual and group counseling, community-level interventions to change injecting norms, and needle syringe programs (NSPs) to provide sterile injection equipment10-13. In Iran, NSPs are well established having been developed and implemented since 2002 14, 15. Although such programs contribute to stabilizing the HIV epidemic among PWID in Iran, unsafe injection and particularly needle/syringe sharing (12.6%) are still reported by PWID9,16,17.

Screening PWID for HIV and HCV infection and providing risk reduction counseling have been recommended by WHO to reduce BBVs transmission18. Evidence supporting effectiveness of HIV and HCV screening and counseling on change in injecting high-risk behaviors among PWID are weak19. BBVs screening and counseling programs among PWID receiving opioid maintenance treatment were moderately cost-effective as compared to no screening. It is also associated with 5% decrease in needle-sharing which improve its cost-effectiveness20.

Few studies internationally have examined the impact of HIV diagnosis on injection risk behaviors19. Most studies on HIV and HCV screening and awareness have relied on cross-sectional study designs and yielded diverse results21. PWID, diagnosed with HIV or HCV, and receive their test result, will subsequently reduce their injecting risk behavior in order to decrease risk of transmitting HIV and HCV to others22. There is no change in injecting drug use behaviors including syringe and other equipment sharing amongst young PWID diagnosed with HCV infection23. An increase in the use of new needles and syringes in the three months following HCV testing and counseling among PWID in Melbourne is reported, but no difference was found between people received positive or negative HCV results24. Hence, it is unclear whether knowing of one’s HIV status influences injecting behaviors and reduces the risk of BBV transmission.

Understanding the fact, that awareness of current HIV status has effect on different behavioral outcomes for PWID is important for policymaking and planning purposes. Our study was an observational study using Coarsened Exact Matching (CEM) to match participants who were aware of their HIV status (positive and negative) with those who were unaware of their current HIV status in order to ensure statistically equivalent comparison groups to estimate the effect HIV status has on injection risk behavior15.

The objectives of the present study were to determine whether PWID knowledge of current BBVs status was associated with a reduction in injecting behavior compared to PWID who do not know their current HIV status. The HIV epidemic in Iran was first observed in Kermanshah in 1996 where the most affected population was PWID. Since then many harm reduction services have been implemented in the city, including the needle and syringe programs (NSPs) and opioid maintenance treatment (OMT) programs. HIV remains highly prevalent among PWID in Kermanshah and The National AIDS Control Program in Iran conduct HIV surveillance for monitoring HIV trends13 and Kermanshah is a sentinel site, we chose it for our study site. This study can provide valuable insights into the effectiveness of current BBV counseling and testing programs and help to provide practical training in the implementation and development of harm-reduction strategies.

Methods

We used data from a cross-sectional survey using snowball sampling to recruit 500 PWID from September to December 2014, in Kermanshah, west of Iran. To be eligible for the study, participants were required to be over 18 years old, to inject illicit drugs at least once in the past month which was verified by presence of "stigmata," or track marks, to be able to speak and comprehend Farsi enough to respond to survey questions and to provide informed consent. Exclusion criteria were history of methamphetamine use in the post month and absence of track marks. All respondents who meet the screening criteria were asked to participate in the study. During data collection, 500 individuals were screened. Among them, 10 individuals were not eligible for participation, and 10 individuals refused.

To gather study data, a structured questionnaire was used by trained interviewers. The questionnaire included modules on socio-demographic characteristics, sexual behaviors, HIV testing, participation in harm reduction program activities, frequency of injection and drug-related risk behaviors such as sharing (borrowing or lending) of syringes/needles and other paraphernalia (i.e., cookers, cotton filters, and rinse water), reuse of syringes and number of injecting partners they have shared syringes/needles with over the past month prior to the interview. We validated the content of our questionnaire with inputs from eight behavioral sciences, epidemiology and harm reduction experts. The study protocol and all the procedures were reviewed and approved by the Research Ethics Committee of the Kerman University of Medical Sciences (KUMS), of approval number: k/93/204.

We assessed six outcomes of interest, all treated as binary variables including not lending needles or syringes in the past month, not borrowing needles or syringes in the past month, reuse of own syringes, not sharing paraphernalia in the past month, and consistent condom use with any type of sexual partner in the past month. The exposure of interest was known HIV status, defined by self-report of current HIV status. Each variable was coded as a dichotomous measure, indicating that some respondents were unaware of their current HIV status. We also considered several other measures. Socio-demographic variables include age, education, occupation and monthly income. Sexual behaviors include total number of sexual partners in the past year, type of sexual partners (commercial, causal, regular), and whether the respondent reported having sex while intoxicated by drugs/alcohol in the past month.

Coarsened Exact Matching (CEM) is a statistical matching technique used to improve causal inferences of observational studies. It is recommended when an experimental design is not feasible. Here CEM was applied to match PWID known to be HIV positive and HIV negative with those PWID who did not know their current HIV status. Covariates were chosen in order to ensure statistically equivalent comparison groups to estimate the effect of HIV status notification on injection risk behaviors. CEM assigns each case into one of a specified set of strata in which members are exactly matched on a set of coarsened, i.e. categorized, variables25. Matched members are then assigned a weight specific to that stratum and representative of the proportion of all members present in the stratum26. Based on the six -selected matching variables, we calculated a statistical measure called L1 distance. It varies between 0 and 1 and any values close to zero mean that the matching is perfect and ensures the comparability of the two groups27. We calculated the L1 before and after applying CEM, and we observed that L1 decreased from 0.37 to 0.00004 after coarsened exact matching indicating minimal imbalance between the two groups we wanted to compare. We then reported the descriptive statistics for the pooled sample and matched sub-sample. We applied a logistic regression to estimate the effect of knowledge of current HIV status on injection high-risk behaviors. The effects were reported as OR and 95%CI. For all analyses P<0.05 was considered significant. All analyses were undertaken in Stata version 12 (Stata Corp, College Station, Texas)

Results

A total of 480 male PWID participated in this study. The characteristics of participants in pooled (unmatched) and matched samples are presented in Table 1. The matched sample (n = 320) had a mean age ± standard deviation (SD) of 33.5 ± 7.6(IQR, 25.6–42.4) yr. The mean and median durations of injection drug use were 6.0 ± 4.6 and 3.2 (IQR, 3.6–11.1) yr. The majority of respondents were single (73%), 53% lived with their families, and 90% had a monthly income of less than $150 (the average family monthly income was $470). While 40% of study subjects did not know their HCV status, 32% reported being HCV positive. Regarding HIV status, 22% did not know their current sero-status and 14% reported themselves as HIV positive.

Table 1. Population characteristics and risk profile for people who inject drugs in matched and unmatched samples of PWID, Kermanshah, west of Iran 2014 .

Variables Pooled sample,
n (%) (n=480)
Matched sample,
n (%) (n=320)
Age (yr)
<30 216 (44.3) 166 (52.4)
30-39 144 (30.2) 90 (28.2)
≥40 120 (25.5) 63 (20.4)
Education
Primary or below 120 (24.2) 64 (20.4)
High school 192 (40.3) 160 (50.3)
Diploma and high 168 (35.5) 96 (39.3)
Marital
Single 336 (70.3) 233 (73.5)
Married 48 (10.2) 26 (8.2)
Divorce 72 (14.2) 38 (11.2)
Widowed 24 (5.3) 23 (7.1)
Monthly income
less than 150 US$ 400 (83.3) 290 (90.4)
150 US$ or more 80 (16.7) 40 (9.6)
Age of first injecting drug use
<25 270 (61.4) 224 (70.1)
25-30 100 (21.3) 64 (20.2)
30 and upper 87 (17.3) 32 (9.7)
Age of first drug use (yr)
<25 417 (87.8) 280 (88.3)
25-30 51 (9.1) 30 (7.6)
≥30 12 (3.1) 10 (2.1)
Aware of HCV Status 303 (63.2) 193 (60.3)
Aware of HIV Status 402 (83.7) 281 (87.8)
Borrowing a syringe in past month 135 (28.2) 80 (25.1)
Lending a used syringe in past month 77 (16.2) 48 (15.3)
Borrowing or lending paraphernalia in past month 283 (58.9) 176 (55.3)
Reuse of own syringes in past month 355 (73.9) 227 (70.9)
Mean number of injecting partners (SD) 2.43 (1.4) 2.2 (1.3)

The mean and standard deviation age of age at first illicit drug use were 22.4 ± 5.6 and (IQR, 20.6–26.1), respectively. About 25% of matched respondents reported “borrowing a syringe” in the past month. Similarly, 15% of matched participants reported “lending a used syringe” to other people within the last month. The recent borrowing or lending of injecting paraphernalia was reported by 55% of participants. In addition, 71% of matched participants reported “reuse of their own syringes” in the month prior to the interview. The mean number of injecting partners whom the study participants had shared syringe/needle or paraphernalia with was 2.28±1.35 (Table 1).

We present the effect of knowing current HIV status, on different injection risk behaviors in the pooled and matched samples in Table 2. In the matched sample, PWID who reported being HIV positive were more likely to report borrowing syringes in past month as compared to PWID who did not know their HIV status and PWID who reported being HIV negative status (OR: 1.7 95% CI:1.32, 2.81 and OR: 1.54, 95% CI:1.28, 2.71). PWID who knew their HIV positive status reported less frequent syringe lending as compared to PWID who did not know their HIV status (OR: 0.22, CI95%: 0.1, 0.84, P=0.022) and PWID who report HIV negative status (OR: 0.25, CI: 95% 0.74, 2.17).

Table 2. Logistic regression estimates of known HIV status and safer injecting practices in matched and unmatched samples of PWID, Kermanshah, west of Iran 2014 .

Behavioral outcomes Pooled sample OR (95% CI) Match sample
OR (95% CI) a
Borrowing a syringe in past month
PWID unaware of HIV status 1.00 1.00
Aware HIV+ status 1.71 (1.30, 1.86) 1.68 (1.32, 2.81)
Aware HIV- status 0.51 (1.23, 1.77) 1.54 (1.28, 2.71)
Lending a syringe in past month
PWID unaware of HIV status 1.00 1.00
Aware HIV+ status 0.25 (0.18, 0.77) 0.22 (0.10, 0.84)
Aware HIV- status 0.34 (0.18, 0.64) 0.31 (0.15, 0.60)
Sharing a paraphernalia in past month
PWID unaware of HIV status 1.00 1.00
Aware HIV+ status 0.7 (0.42, 1.75) 0.68 (0.30, 2.32)
Aware HIV- status 0.89 (0.43, 2.04) 0.78 (0.47, 3.22)
Syringe reuse in past month
PWID don’t Know HIV status 1.00 1.00
To know HIV+ status 2.31(1.19,4.51) 2.38 (1.60, 4.68)
To know HIV- status 3.44 (1.27,5.72) 3.54 (1.30, 5.42)
Consistent condom use with any type of sexual partner
PWID unaware of HIV status 1.00 1.00
Aware HIV+ status 3.34 (1.70, 5.20) 3.22 (1.50, 4.80)
Aware HIV- status 3.24 (1.90, 4.86) 3.19 (1.50, 4.60)

aThe matched subsample was made by considering age, income, education, access to NSP facilities and city of residence.

Participants reported reuse of their own syringe more frequently, if they knew they were HIV positive (OR: 2.38, 95% CI: 1.6, 4.68, P=0.031) as compared to PWID who did not know their current HIV status or reported HIV negative status. Reporting being HIV positive or negative increased the chance of syringe reuse by 3.54 and 2.38, respectively. Recent paraphernalia sharing was reported less among PWID who were known to be HIV positive (OR: 0.86, 95%CI: 0.30, 2.32, P=0.311) or negative as compared to PWID who did not know their current HIV status (OR: 0.78, 95% CI: 0.47, 3.38, P=0.231). However, neither was statistically significant. There was a statistically significant relationship between awareness of current HIV status with consistent condom use with all sexual partners (regular, casual or paid) (OR: 3.22 95% CI: 1.5, 4.8).

Discussion

Using the matched analysis, we found that reporting being HIV positive was associated with more borrowing and reuse of own used syringes and less lending syringes. Recent researches from both Australia and Canada have suggested there were protective behavioral changes for PWID associated with the current BBVs notification process22,24. The concept of “teachable moment” has been introduced, to describe health conditions, which motivate individuals to adopt risk-reduction health behaviors19. We observed a significant effect of HIV positive status notification on needle and syringe borrowing. This finding is in line with evidence from France, where HIV-positive PWIDs who were aware of their sero-status were more likely to borrow injection paraphernalia28. In Baltimore, PWID who reported awareness of their HCV status were more likely to share as compared with those who were unaware of their status22. Qualitative evidence from the United Kingdom, suggests that PWID infected with HIV and HCV were less likely to be concerned about borrowing injecting equipment from others, based on the assumption that they were already infected29. For PWID who know their HIV positive status, this may be a cue prompting motivation for change to improve their own health19. These findings emphasis the importance of providing education and counseling30 on ongoing risk posed by other BBVs for HIV positive PWID in harm reduction programs.

Similarly to France, where HCV positive PWID who were aware of their status were less likely to lend syringes to others30, PWID in our study who reported currently being HIV positive were more likely to decrease their frequency of lending their own used needles and syringes. This is likely due to their conscious desire to prevent the BBVs transmission to others. In Montréal, Canada participants reported a decrease in syringe sharing as well as cocaine and heroin injection following notification of their BBVs results whether positive or negative19. Together with the findings from our study, these suggest a need to strengthen current HIV and HCV testing programs. Expanding current counseling and testing programs, developing targeted testing for PWID, and providing diverse platforms to share HIV and HCV risk reduction information will add considerable value to current prevention efforts.

In this analysis, we found a statistically significant relationship between the reuse of PWID own syringes and awareness of their HIV status. Our findings show indirect sharing of other injection paraphernalia (i.e., cookers, cotton filters, and rinse water) was reportedly less among PWID who know their current HIV status; however, these were not statistically significant. Previous studies have shown no change in injecting equipment borrowing following a diagnosis of HCV infection amongst young PWID in US22,24. This may be due to lack of young PWID’s knowledge regarding risk of BBVs’ transition through sharing paraphernalia. Recent studies have highlighted the risk of BBVs with suggestions that one-half of the new HCV infections observed among PWID can be accounted for through indirect sharing of injection equipment (i.e., cookers and cotton and filters) 18,30-32. Our finding that more than half the PWID who knew they were HIV positive continued to report the sharing of injection equipment highlights the need for targeted behavioral interventions to reduce these high-risk behaviors. In particular, PWID in our study appear to be unaware of the risks of BBVs transmission associated with indirect sharing of injection equipment.

This study is a post hoc analysis of data from a study designed to investigate risk-behaviors for HIV infection among PWID in Iran. This was not a study to assess the impact of HIV counseling and testing on risk behaviors. However, our findings provide valuable insight into the effect of HIV status awareness on injecting risk behaviors.

There are limitations to our study. Like any observational study, we can only report the association of exposure with high-risk behaviors. Furthermore, our data were based on participants self-report, therefore may be subject to recall and/or social desirability bias33. We might also misclassify PWID based on knowing their HIV status as it was based on their self-report. This may lead to attenuating the true differences in the effect of the two groups. We matched the three groups based on age, income, education, access to NSP facilities and city residence; however, we could not account for other factors such, access to methadone maintenance therapy.

Conclusions

A large reduction in risky behaviors was observed among PWID who were aware of their current HIV status. HIV status notification, whether results are positive or negative, could enhance the impact of counseling and the willingness of PWID to initiate injecting related changes in behaviors. Our study highlights the need to link regular HIV counseling and testing with drug treatment and harm reduction programs for all PWID.

Acknowledgments

We gratefully thank all staff in the drop-in centers (DICs) in Kermanshah who contributed in recruiting (Ms. Barkhordar) and data collection/interview (Mr. Azad and Mr. Amini). We thank participants for their time and interest in the study. We also want to appreciate Mostafa Shokohi from the Regional Knowledge Hub for HIV Surveillance who provided valuable input to the study protocol and the questionnaire.

Authors’ contributions: Study concept and design: HS and AM. Analysis and interpretation of data: MN and SH. Drafting the manuscript: MN, AM and AN. Critical revision of the manuscript: AN, PH, HS, SH, AH and AM.

This research funded by Substance Abuse Prevention and Treatment Office (SAPTO) of Mental Health, Social Health and Addiction Department (MeHSHAD) of Ministry of Health and Medical Education, I.R. of Iran.

Conflict of interest statement

All other authors have no conflicts of interest to be declared.

Highlights

  • We found that reporting being HIV positive was associated with more borrowing and reuse of own used syringes and less lending syringes.

  • PWID who reported currently being HIV positive were more likely to decrease their frequency of lending their own used needles and syringes.

  • Strategies to scale up HIV testing for PWID which also increase awareness of HIV status may decrease injecting related the risk behaviors.

Citation: Noroozi A, Mirzazadeh A, Farhoudian A, Hajebi A, Khankeh HR, Higgs P, Sharifi H, Armoon B, Noroozi M. Impact of HIV Status Notification on Risk Behaviors among Men Who Inject Drugs in Kermanshah, West of Iran. J Res Health Sci. 2016; 16(3):116-121.

References

  • 1.Arreola S, Bluthenthal RN, Wenger L, Chu D, Thing J, Kral AH. Characteristics of people who initiate injection drug use later in life. Drug Alcohol Depen. 2014;138:244–250. doi: 10.1016/j.drugalcdep.2014.02.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Alipour A, Haghdoost AA, Sajadi L, Zolala F. HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey. Sex Transm Infect. 2010;89(Suppl 3):iii41–iii44. doi: 10.1136/sextrans-2013-051201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Broz D, Pham H, Spiller M, Wejnert C, Le B, Neaigus A. et al. Prevalence of HIV infection and risk behaviors among younger and older injecting drug users in the United States, 2009. AIDS Behav. 2014;18(3):284–296. doi: 10.1007/s10461-013-0660-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Noroozi M, Mirzazadeh A, Noroozi A, Mehrabi Y, Hajebi A, Zamani S. et al. Client-level coverage of needle and syringe program and high-risk injection behaviors: a case study of people who inject drugs in Kermanshah, Iran. Addict Health. 2015;7(3-4):164–173. [PMC free article] [PubMed] [Google Scholar]
  • 5.Eshrati B, Taghizadeh Asl R, Dell CA, Afshar P, MargaretE Millson P, Kamali M. et al. Preventing HIV transmission among Iranian prisoners: initial support for providing education on the benefits of harm reduction practices. Harm Reduct J. 2008;5(21):1–7. doi: 10.1186/1477-7517-5-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Haghdoost AA, Mostafavi E, Mirzazadeh A, Navadeh S, Feizzadeh A, Fahimfar N. et al. Modelling of HIV/AIDS in Iran up to 2014. J Aids Hiv Res. 2011;3(12):231–239. [Google Scholar]
  • 7.Nasirian M, Doroudi F, Gooya MM, Sedaghat A, Haghdoost AA. Modeling of human immunodeficiency virus modes of transmission in iran. J Res Health Sci. 2012;12(2):81–87. [PubMed] [Google Scholar]
  • 8. National AIDS Committee Secretariat. Islamic Republic of Iran AIDS Progress Report: On Monitoring of the United Nations General Assembly Special Session on HIV and AIDS. Tehran: Ministry of Health and Medical Education; 2015.
  • 9.Rahimi-Movaghar A, Amin-Esmaeili M, Haghdoost AA, Sadeghirad B, Mohraz M. HIV prevalence amongst injecting drug users in Iran: a systematic review of studies conducted during the decade 1998–2007. Int J Drug Policy. 2012;23(4):271–278. doi: 10.1016/j.drugpo.2011.09.002. [DOI] [PubMed] [Google Scholar]
  • 10.Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet. 2008;372(9639):669–684. doi: 10.1016/S0140-6736(08)60886-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Fung IC, Guinness L, Vickerman P, Watts C, Vannela G, Vadhvana J. et al. Modelling the impact and cost-effectiveness of the HIV intervention programme amongst commercial sex workers in Ahmedabad, Gujarat, India. BMC Public Health. 2007;7(1):195. doi: 10.1186/1471-2458-7-195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Islam MM, Wodak A, Conigrave KM. The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings. Int J Drug Policy. 2008;19(6):436–441. doi: 10.1016/j.drugpo.2007.07.006. [DOI] [PubMed] [Google Scholar]
  • 13. Noroozi A, Mirzazadeh A, Hajebi A, Farhoudian A, Sharifi H, Higgs P, et al. Comparing profile of people who inject drugs (PWID) accessing different types of needle and syringe programs or secondary distribution in Kermanshah, Iran. J Subst Use. 2016:In press.
  • 14.Mirahmadizadeh A, Majdzadeh R, Mohammad K, Forouzanfar M. Prevalence of HIV and hepatitis C virus infections and related behavioral determinants among injecting drug users of drop-in centers in Iran. Iran Red Crescent Med J. 2009;11(3):325–329. [Google Scholar]
  • 15.Nazari SSH, Noroozi M, Soori H, Noroozi A, Mehrabi Y, Hajebi A. et al. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran. Int J Drug Policy. 2016;27:127–131. doi: 10.1016/j.drugpo.2015.10.011. [DOI] [PubMed] [Google Scholar]
  • 16.Khajehkazemi R, Osooli M, Sajadi L, Karamouzian M, Sedaghat A, Fahimfar N, Safaie A. et al. HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey. Sex Transm Infect. 2013;89(Suppl 3):iii29–iii32. doi: 10.1136/sextrans-2013-051204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Noroozi MM, Nejat S, Golestan B, Majdzadeh R. What are differences between non-injecting and injecting drug addicts? Int J Prev Med. 2012;3(6):414–419. [PMC free article] [PubMed] [Google Scholar]
  • 18.Aspinall E, Weir A, Sacks-Davis R, Spelman T, Grebely J, Higgs P. et al. Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study. Int J Drug Policy. 2014;25(1):179–182. doi: 10.1016/j.drugpo.2013.08.005. [DOI] [PubMed] [Google Scholar]
  • 19.Bruneau J, Zang G, Abrahamowicz M, Jutras-Aswad D, Daniel M, Roy É. Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study. Clin Infect Dis. 2014;58(6):755–761. doi: 10.1093/cid/cit938. [DOI] [PubMed] [Google Scholar]
  • 20.Cipriano LE, Zaric GS, Holodniy M, Bendavid E, Owens DK, Brandeau ML. Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users. PLoS One. 2012;7(9):e45176. doi: 10.1371/journal.pone.0045176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.McCUSKER M. Influence of hepatitis C status on alcohol consumption in opiate users in treatment. Addiction. 2001;96(7):1007–1014. doi: 10.1046/j.1360-0443.2001.967100710.x. [DOI] [PubMed] [Google Scholar]
  • 22.Ompad DC, Fuller CM, Vlahov D, Thomas D, Strathdee SA. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clin Infect Dis. 2002;35(7):783–788. doi: 10.1086/342063. [DOI] [PubMed] [Google Scholar]
  • 23.Tsui JI, Vittinghoff E, Hahn JA, Evans JL, Davidson PJ, Page K. Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco. Drug Alcohol Depen. 2009;105(1):160–163. doi: 10.1016/j.drugalcdep.2009.05.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Aitken CK, Kerger M, Crofts N. Peer-delivered hepatitis C testing and counselling: a means of improving the health of injecting drug users. Drug Alcohol Rev. 2002;21(1):33–37. doi: 10.1080/09595230220119327. [DOI] [PubMed] [Google Scholar]
  • 25.Sidney J, Coberley C, Pope J, Wells A. Extending coarsened exact matching to multiple cohorts: an application to longitudinal well-being program evaluation within an employer population. Health Serv Outcomes Res Methodol. 2015;15(2):136–156. [Google Scholar]
  • 26.Wang K, Hongyun FU, Longfield K, Modi S, Mundy G, Firestone R. Do community-based strategies reduce HIV risk among people who inject drugs in China? A quasi-experimental study in Yunnan and Guangxi provinces. Harm Reduct J. 2014;12:1–9. doi: 10.1186/1477-7517-11-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Stuart EA. Matching methods for causal inference: A review and a look forward. Stat Sci. 2010;25(1):1–21. doi: 10.1214/09-STS313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Vidal-Trécan G, Coste J, Varescon-Pousson I, Christoforov B, Boissonnas A. HCV status knowledge and risk behaviours amongst intravenous drug users. Eur J Epidemiol. 2000;16(5):439–445. doi: 10.1023/a:1007622831518. [DOI] [PubMed] [Google Scholar]
  • 29.Craine N, Walker M, Carnwath T, Klee H. Hepatitis C testing and injecting risk behaviour: the results of a UK based pilot study. Int J Drug Policy. 2004;15(2):115–122. [Google Scholar]
  • 30.Miller CL, Pearce ME, Moniruzzaman A, Thomas V, Christian W. Schechter M T, et al The Cedar Project: risk factors for transition to injection drug use among young, urban Aboriginal people. Can Med Assoc J. 2011;183(10):1147–1154. doi: 10.1503/cmaj.101257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Foss AM, Hossain M, Vickerman PT, Watts CH. A systematic review of published evidence on intervention impact on condom use in sub-Saharan Africa and Asia. Sex Transm Infect. 2007;83(7):510–516. doi: 10.1136/sti.2007.027144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Horyniak D, Dietze P, Degenhardt L, Higgs P, McIlwraith F, Alati R. et al. The relationship between age and risky injecting behaviours among a sample of Australian people who inject drugs. Drug Alcohol Depen. 2013;132(3):541–546. doi: 10.1016/j.drugalcdep.2013.03.021. [DOI] [PubMed] [Google Scholar]
  • 33.Noroozi A, Mirzazadeh A, Hajebi A, Farhoudian A, Sharifi H, Higgs P. et al. Comparing profile of people who inject drugs (PWID) accessing different types of needle and syringe programs or secondary distribution in Kermanshah, Iran. J Subst Use. 2016:1–6. [Google Scholar]

Articles from Journal of Research in Health Sciences are provided here courtesy of School of Public Health, Hamadan University of Medical Sciences

RESOURCES